MedTrace Logo

Naloxegol Drug Utilization Post Authorisation Safety Study

NCT02813148 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17254

Last updated 2024-07-23

No results posted yet for this study

Summary

This post-authorization observational safety study determines the characteristics of patients prescribed naloxegol at time of first prescription and treatment patterns of naloxegol in follow-up in the United Kingdom (UK), Norway, Sweden, and Germany.

Conditions

  • Opioid Induced Constipation

Interventions

DRUG

Naloxegol

Non-interventional study of drug utilization

Sponsors & Collaborators

  • Kyowa Kirin Pharmaceutical Development Ltd

    lead INDUSTRY

Principal Investigators

  • Rob Swain · Kyowa Kirin, Inc.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2019-06-30
Completion
2020-01-31

Countries

  • Germany
  • Norway
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02813148 on ClinicalTrials.gov